What is the impact of PPAR-gamma agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.5, pp.1399-1408, 2020 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 50 Issue: 5
- Publication Date: 2020
- Doi Number: 10.3906/sag-2002-117
- Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
- Page Numbers: pp.1399-1408
- Keywords: Hysterectomy, ovarian reserve, rat, Doppler ultrasonography, PPAR gamma, rosiglitazone, ANTI-MULLERIAN HORMONE, TOTAL ABDOMINAL HYSTERECTOMY, ESTROUS-CYCLE, PREMENOPAUSAL WOMEN, SERUM FSH, EXPRESSION, AGE
- Ankara University Affiliated: Yes
Abstract
Background/aim: To evaluate the effects of hysterectomy on rat ovaries and the possible protective role of peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist-rosiglitazone against ovarian reserve decrement.